Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$826,263
-$19,434 QoQ
Shares Held
6,540
+7.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,157
of 2,266 holders
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 82%
Shared 15%
None 3%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gryphon Financial Partners LLC holds $43,846,091 across 10 Drug Manufacturers - General names. GILD ranks #6 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
91,741 | $23,085,705 | |
| 2 | LLY |
ELI LILLY & Co
|
6,418 | $7,697,942 | |
| 3 | JNJ |
Johnson & Johnson
|
25,825 | $6,558,775 | |
| 4 | AMGN |
Amgen Inc
|
5,868 | $2,124,920 | |
| 5 | MRK |
Merck & Co., Inc.
|
16,044 | $2,061,654 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
6,540 | $826,263 | |
| 7 | GSK |
GSK plc
|
15,580 | $816,703 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,157 | $239,526 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $826,263 | 6,540 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $845,697 | 6,068 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $604,862 | 4,928 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $487,734 | 4,394 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $220,297 | 1,987 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $209,757 | 1,872 | Shares | Sole | 2025-05-12 | |
| 2020-03-31 | $1,667,595 | 22,306 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||